The Global Ranitidine Market is expected to grow at a compound annual growth rate of 2.60% in the forecast period of 2021 to 2028 and is expected to reach USD 502.4 million by 2028. The rise in gastroesophageal reflux disease complications and acid reflux by foods, drinks and other medicine are significant factors driving the market growth rate.
Likewise, the rise in the disposable income of consumers in emerging economies and increase in the prescription for ranitidine will produce lucrative opportunities for the growth of the ranitidine market.
Ranitidine Market Scenario
According to Data Bridge Market Research the market for ranitidine is expected to gain growth because of the rise in the gluten intake. Also the rise in the in acidity or heartburn problems and rapid change in the food habits are also expected to fuel the demand of the ranitidine market over the forecast period of 2021 to 2028. Whereas, the rise in the alternative in the market and various side-effect of ranitidine are expected to hinder the growth of the ranitidine market in the aforementioned forecast period.
Now the question is which are the other regions that ranitidine market is targeting? Data Bridge Market Research has estimated large growth in Asia-Pacific due to rise in the healthcare expenditure and increase in the disposable income.
For more analysis on the ranitidine request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-ranitidine-market
Ranitidine Market Scope
Ranitidine market is segmented on the basis of countries into the U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
- All country based analysis of ranitidine market is further analyzed based on maximum granularity into further segmentation. On the basis of indication, the ranitidine market is segmented into intestinal & stomach ulcers, gastroesophageal reflux disease (GERD), esophagitis, zollinger-ellison syndrome, and others. On the basis of population type, the ranitidine market is segmented into children and adults. On the basis of dosage form, the ranitidine market is segmented into solid oral, liquid and parenteral. On the basis of dosage strength, the ranitidine market is segmented into oral strength and parenteral strength. On the basis of mode of purchase, the ranitidine market is segmented into over the counter and prescription. On the basis of end user, the ranitidine market is segmented into hospitals, specialty clinics and others. On the basis of distribution channel, the ranitidine market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
- Ranitidine is a type of a medicine which helps to decrease the stomach acid production. It is usually used in treatment of gastroesophageal reflux disease, peptic ulcer disease and Zollinger–Ellison syndrome.
To know more about the study, https://www.databridgemarketresearch.com/reports/global-ranitidine-market
Key Pointers Covered in the Ranitidine Market Industry Trends and Forecast to 2028
- Market Size
- Market New Sales Volumes
- Market Replacement Sales Volumes
- Market Installed Base
- Market By Brands
- Market Procedure Volumes
- Market Product Price Analysis
- Market Healthcare Outcomes
- Market Cost of Care Analysis
- Market Regulatory Framework and Changes
- Prices and Reimbursement Analysis
- Market Shares in Different Regions
- Recent Developments for Market Competitors
- Market Upcoming Applications
- Market Innovators Study
Key Market Competitors Covered in the Report
- Sanofi
- GENPHARM
- Sandoz International GmbH
- Teva Pharmaceuticals USA Inc
- GlaxoSmithKline plc
- Mylan N.V
- Par Pharmaceutical
- Perrigo Company plc
- Sun Pharmaceuticals Industries Ltd
- Amneal Pharmaceuticals, LLC
- Strides Pharma Science Limited
- Dr. Reddy’s Laboratories Ltd
- Laboratoire Riva
- Pharmascience Inc
- Vita Health Products Inc
Above are the key players covered in the report, to know about more and exhaustive list of ranitidine companies’ contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-ranitidine-market
Research Methodology of Global Ranitidine Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Related Reports
- Global Gastric Ulcers Market - Industry and Forecast to 2028
- Global Gastroesophageal Reflux Disease Market - Industry Trends and Forecast to 2028
- Global Acidity Regulators Market - Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports @ https://www.databridgemarketresearch.com/report-category/healthcare/
